Breast Cancer Following Radiation for Hodgkin Lymphoma: Clinical Scenarios and Risk-Reducing Strategies

被引:1
作者
Overholser, Linda [1 ]
Shagisultanova, Elena [2 ,3 ]
Rabinovitch, Rachel A. [4 ]
Kounalakis, Nicole [5 ]
Diamond, Jennifer [3 ]
Finlayson, Christina A. [5 ]
Fisher, Christine M. [4 ]
Kabos, Peter [3 ]
Elias, Anthony D. [3 ]
Borges, Virginia F. [2 ,3 ]
Mayordomo, Jose [3 ]
机构
[1] Univ Colorado, Div Internal Med, Anschutz Med Campus, Aurora, CO USA
[2] Univ Colorado, Ctr Canc, Young Womens Breast Canc Translat Program, Aurora, CO USA
[3] Univ Colorado, Div Med Oncol, Anschutz Med Campus,1665 Aurora Court,MS F724, Aurora, CO 80045 USA
[4] Univ Colorado, Dept Radiat Oncol, Anschutz Med Campus, Aurora, CO USA
[5] Univ Colorado, Dept Surg, Anschutz Med Campus, Aurora, CO USA
来源
ONCOLOGY-NEW YORK | 2016年 / 30卷 / 12期
关键词
YOUNG-ADULT CANCER; CHEST RADIATION; CHILDHOOD-CANCER; PREVENTION TRIAL; FEMALE SURVIVORS; PEDIATRIC CANCER; ONCOLOGY GROUP; WOMEN; TAMOXIFEN; DISEASE;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Since most patients with Hodgkin lymphoma survive their disease, long-term issues such as development of second primary malignancies arise, especially in patients treated with multimodal therapy including radiation therapy plus chemotherapy. The risk of breast cancer is significantly elevated in women exposed to high-dose ionizing radiation to the chest before age 40. The case of a 48-year-old patient with a lump in her right breast is presented as a clinical scenario in this article. We review available strategies for screening and risk reduction through chemoprevention or risk-reducing surgery, as well as challenges for management of breast cancer in patients with prior exposure to radiation for Hodgkin lymphoma. The Children's Oncology Group clinical practice guidelines for long-term followup care of pediatric cancer survivors provide recommendations that have been endorsed by American and European oncologists.
引用
收藏
页码:1063 / 1070
页数:8
相关论文
共 50 条
  • [1] Sequence of radiotherapy with tamoxifen in conservatively managed breast cancer does not affect local relapse rates
    Ahn, PH
    Vu, HT
    Lannin, D
    Obedian, E
    DiGiovanna, MP
    Burtness, B
    Haffty, BG
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (01) : 17 - 23
  • [2] Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial
    Albain, Kathy S.
    Barlow, William E.
    Ravdin, Peter M.
    Farrar, William B.
    Burton, Gary V.
    Ketchel, Steven J.
    Cobau, Charles D.
    Levine, Ellis G.
    Ingle, James N.
    Pritchard, Kathleen I.
    Lichter, Allen S.
    Schneider, Daniel J.
    Abeloff, Martin D.
    Henderson, I. Craig
    Muss, Hyman B.
    Green, Stephanie J.
    Lew, Danika
    Livingston, Robert B.
    Martino, Silvana
    Osborne, C. Kent
    [J]. LANCET, 2009, 374 (9707) : 2055 - 2063
  • [3] [Anonymous], 2015, Breast Cancer Facts Figures 2015-2016
  • [4] Barriers to the Use of Breast Cancer Risk Reduction Therapies
    Bambhroliya, Arvind
    Chavez-MacGregor, Mariana
    Brewster, Abenaa M.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (07): : 927 - 935
  • [5] Breast Cancer Risk Reduction, Version 2.2015
    Bevers, Therese B.
    Ward, John H.
    Arun, Banu K.
    Colditz, Graham A.
    Cowan, Kenneth H.
    Daly, Mary B.
    Garber, Judy E.
    Gemignani, Mary L.
    Gradishar, William J.
    Jordan, Judith A.
    Korde, Larissa A.
    Kounalakis, Nicole
    Krontiras, Helen
    Kumar, Shicha
    Kurian, Allison
    Laronga, Christine
    Layman, Rachel M.
    Loftus, Loretta S.
    Mahoney, Martin C.
    Merajver, Sofia D.
    Meszoely, Ingrid M.
    Mortimer, Joanne
    Newman, Lisa
    Pritchard, Elizabeth
    Pruthi, Sandhya
    Seewaldt, Victoria
    Specht, Michelle C.
    Visvanathan, Kale
    Wallace, Anne
    Bergman, Mary Ann
    Kumar, Rashmi
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (07): : 880 - 915
  • [6] High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: Report from the late effects study group
    Bhatia, S
    Yasui, Y
    Robison, LL
    Birch, JM
    Bogue, MK
    Diller, L
    DeLaat, C
    Fossati-Bellani, F
    Morgan, E
    Oberlin, O
    Reaman, G
    Ruymann, FB
    Tersak, J
    Meadows, AT
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (23) : 4386 - 4394
  • [7] Prophylactic Mastectomy: Who Needs It, When and Why
    Burke, Erin E.
    Portschy, Pamela R.
    Tuttle, Todd M.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2015, 111 (01) : 91 - 95
  • [8] Subsequent malignancies in children treated for Hodgkin's disease: Associations with gender and radiation dose
    Constine, Louis S.
    Tarbell, Nancy
    Hudson, Melissa M.
    Schwartz, Cindy
    Fisher, Susan G.
    Muhs, Ann G.
    Basu, Swati K.
    Kun, Larry E.
    Ng, Andrea
    Mauch, Peter
    Sandhu, Ajay
    Culakova, Eva
    Lyman, Gary
    Mendenhall, Nancy
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : 24 - 33
  • [9] Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial
    Cuzick, Jack
    Sestak, Ivana
    Cawthorn, Simon
    Hamed, Hisham
    Holli, Kaija
    Howell, Anthony
    Forbes, John F.
    [J]. LANCET ONCOLOGY, 2015, 16 (01) : 67 - 75
  • [10] Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data
    Cuzick, Jack
    Sestak, Ivana
    Bonanni, Bernardo
    Costantino, Joseph P.
    Cummings, Steve
    DeCensi, Andrea
    Dowsett, Mitch
    Forbes, John F.
    Ford, Leslie
    LaCroix, Andrea Z.
    Mershon, John
    Mitlak, Bruce H.
    Powles, Trevor
    Veronesi, Umberto
    Vogel, Victor
    Wickerham, D. Lawrence
    [J]. LANCET, 2013, 381 (9880) : 1827 - 1834